Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Lipid Modification
100%
Mitochondrial Dysfunction
100%
Liver Disease Progression
100%
Nonalcoholic Steatohepatitis
25%
Mitochondrial Function
16%
Hepatic Lipid
16%
L-carnitine
16%
Lipid Species
16%
Cardiolipin
16%
Ubiquinone
16%
Obese Patients
8%
Biopsy Specimen
8%
Obesity
8%
Lipid Metabolism
8%
Negative Association
8%
Disease Progression
8%
Hepatocytes
8%
Phosphatidylcholine
8%
Liver Biopsy
8%
Lipid Analysis
8%
Lipid Levels
8%
Odd-chain
8%
Liver Steatohepatitis
8%
Liver Disease Severity
8%
Branched-chain Amino Acid Metabolism
8%
Hepatic Lipidome
8%
Metabolic Comorbidities
8%
Plasma Biopsy
8%
Severe Liver Injury
8%
INIS
diseases
100%
liver
100%
mitochondria
100%
lipids
100%
levels
15%
chains
10%
cardiolipin
10%
ubiquinone
10%
data
5%
patients
5%
biopsy
5%
damage
5%
gain
5%
amino acids
5%
metabolism
5%
fats
5%
hepatocytes
5%
accumulation
5%
obesity
5%
plasma
5%
phosphatidylcholine
5%
catabolism
5%
Biochemistry, Genetics and Molecular Biology
Lipid
100%
Mitochondrial Disorder
100%
Lipid Liver Level
40%
Ubiquinone
40%
Cardiolipin
40%
Lipid Metabolism
20%
Amino Acids
20%
Hepatocyte
20%
Lipid Level
20%
Lipidomics
20%
Lipidome
20%
Blood Plasma
20%
Lecithin
20%
Comorbidity
20%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Disease Exacerbation
100%
Mitochondrial Disorder
100%
Acylcarnitine
13%
Ubiquinone
13%
Cardiolipin
13%
Lipid Metabolism
6%
Liver Biopsy
6%
Disease Severity
6%
Hepatocyte
6%
Biopsy Sample
6%
Liver Injury
6%
Branched Chain Amino Acid
6%
Lipidomics
6%
Egg Lecithin
6%
Lipidome
6%
Comorbidity
6%
Pharmacology, Toxicology and Pharmaceutical Science
Disease Exacerbation
100%
Nonalcoholic Fatty Liver
100%
Acylcarnitine
13%
Cardiolipin
13%
Ubiquinone
13%
Disease Severity
6%
Branched Chain Amino Acid
6%
Liver Injury
6%
Egg Lecithin
6%
Lipidome
6%
Comorbidity
6%